Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Cannabis Sativa Company

CBDS
US13764T1051
A1W820

Price

0.01
Today +/-
-0.00
Today %
-2.20 %
P

Cannabis Sativa stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Cannabis Sativa stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Cannabis Sativa stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Cannabis Sativa stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Cannabis Sativa's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Cannabis Sativa Stock Price History

DateCannabis Sativa Price
10/30/20240.01 undefined
10/29/20240.01 undefined
10/28/20240.01 undefined
10/25/20240.01 undefined
10/24/20240.01 undefined
10/23/20240.01 undefined
10/22/20240.01 undefined
10/21/20240.01 undefined
10/18/20240.01 undefined
10/17/20240.01 undefined
10/16/20240.01 undefined
10/15/20240.01 undefined
10/14/20240.01 undefined
10/11/20240.01 undefined
10/10/20240.01 undefined
10/9/20240.01 undefined
10/8/20240.01 undefined
10/7/20240.01 undefined
10/4/20240.01 undefined
10/3/20240.01 undefined

Cannabis Sativa Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Cannabis Sativa, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Cannabis Sativa from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Cannabis Sativa’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Cannabis Sativa. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Cannabis Sativa’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Cannabis Sativa’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Cannabis Sativa’s growth potential.

Cannabis Sativa Revenue, EBIT and net profit per share

DateCannabis Sativa RevenueCannabis Sativa EBITCannabis Sativa Net Income
20231.17 M undefined-855,850 undefined-1.39 M undefined
20221.56 M undefined-1.32 M undefined-1.13 M undefined
20211.84 M undefined-1.75 M undefined-2.45 M undefined
20201.94 M undefined-1.79 M undefined-2.17 M undefined
20191.16 M undefined-2.43 M undefined-3.94 M undefined
2018510,000 undefined-3.87 M undefined-4.13 M undefined
2017320,000 undefined-6.87 M undefined-7.56 M undefined
201630,000 undefined-2.82 M undefined-3.13 M undefined
201510,000 undefined-8.97 M undefined-9.43 M undefined
201410,000 undefined-1.32 M undefined-14.37 M undefined
20130 undefined-190,000 undefined-32.55 M undefined
2012150,000 undefined-40,000 undefined-40,000 undefined
2011180,000 undefined-10,000 undefined-20,000 undefined
2010170,000 undefined-40,000 undefined-40,000 undefined
2009180,000 undefined-40,000 undefined-40,000 undefined
2008230,000 undefined0 undefined0 undefined
2007220,000 undefined20,000 undefined10,000 undefined

Cannabis Sativa Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (k)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (k)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20072008200920102011201220132014201520162017201820192020202120222023
0000000000001,0001,0001,0001,0001,000
-----------------
-------------100.00100.00--
00000000000001,0001,00000
0000000-1-8-2-6-3-2-1-1-10
-------------200.00-100.00-100.00-100.00-
000000-32-14-9-3-7-4-3-2-2-1-1
--------56.25-35.71-66.67133.33-42.86-25.00-33.33--50.00-
1.31.31.31.31.31.317.8312.5716.2317.8719.9221.0221.6625.4129.2838.0754.55
-----------------
Details

Keystats

ⓘ

Revenue and Growth

The Cannabis Sativa Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Cannabis Sativa is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (k)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (k)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (k)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (M)
20072008200920102011201220132014201520162017201820192020202120222023
                                 
4010100100103050260180350340320400480149.76
000000000001000000
00000000000000000
00000002020101010060000
000000.0100.630.010.21.310.030.050.01000.01
0.040.010.0100.010.010.010.680.080.471.50.40.390.390.40.480.16
10070402000010001010102500402.44
000000001000050200000
000000000200000000
000000032.92.942.852.290.70.490.320.160.01
0000000000.253.352.171.841.841.841.841.78
000000000400006006075.05
0.10.070.040.020003.012.913.256.214.472.62.842.162.11.86
0.140.080.050.020.010.010.013.692.993.727.714.872.993.232.562.582.02
                                 
0000001020202020202030305088.82
0.230.230.230.230.230.240.0346.6158.6161.8270.7872.9774.8377.6679.1580.9481.39
-0.18-0.18-0.22-0.26-0.27-0.32-32.55-46.92-56.09-59.23-66.79-70.92-74.86-77.03-79.48-80.6-82.08
0000000000190000000
00000000000000000
0.050.050.01-0.03-0.04-0.08-32.51-0.292.542.614.22.07-0.010.66-0.30.39-0.6
40101010101010480330180110110160180100160175.07
000101020010000001802005030.36
00000032.3100.090.240.770.5300.04000
0000000.22.470.030.450.620.931.021.161.220.090.16
501030404060000000000170118.82
0.090.020.040.060.060.0932.522.960.450.871.51.571.181.561.520.470.49
1000000201,000000000000
00000000000000000
0100000000000640200430777.75
10100000201,0000000640200430777.75
0.10.030.040.060.060.0932.543.960.450.871.51.571.821.581.520.91.26
0.150.080.050.030.020.010.033.672.993.485.73.641.812.241.221.290.66
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Cannabis Sativa provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Cannabis Sativa's financial health and stability.

Assets

Cannabis Sativa's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Cannabis Sativa must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Cannabis Sativa after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Cannabis Sativa's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (k)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2007200820092010201120122013201420152016201720182019202020212022
000000-32-14-9-3-7-4-4-2-2-1
0000000000000000
0000000000000000
00000032000100000
00000001392433110
0000000000000000
0000000000000000
0000000000000000
0000000000000000
0000000000000000
0000000000000000
0000000000000000
0000000000000000
0000000000000000
00000000001,00000000
----------------
0000000000000000
0000000000000000
0.050.01-0.02-0.010-0.02-0.25-0.43-0.34-0.25-1.12-0.690.09-0.25-0.25-0.24
0000000000000000

Cannabis Sativa stock margins

The Cannabis Sativa margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cannabis Sativa. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cannabis Sativa.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Cannabis Sativa's sales revenue. A higher gross margin percentage indicates that the Cannabis Sativa retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Cannabis Sativa's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Cannabis Sativa's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Cannabis Sativa's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Cannabis Sativa. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Cannabis Sativa's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Cannabis Sativa Margin History

Cannabis Sativa Gross marginCannabis Sativa Profit marginCannabis Sativa EBIT marginCannabis Sativa Profit margin
202365.86 %-72.91 %-118.6 %
202261.54 %-84.62 %-72.44 %
202161.96 %-95.11 %-133.15 %
202061.86 %-92.27 %-111.86 %
201960.34 %-209.48 %-339.66 %
201858.82 %-758.82 %-809.8 %
201750 %-2,146.88 %-2,362.5 %
201665.86 %-9,400 %-10,433.33 %
201565.86 %-89,700.01 %-94,300.01 %
201465.86 %-13,200 %-143,700 %
201365.86 %0 %0 %
201293.33 %-26.67 %-26.67 %
201183.33 %-5.56 %-11.11 %
201076.47 %-23.53 %-23.53 %
200977.78 %-22.22 %-22.22 %
200873.91 %0 %0 %
200777.27 %9.09 %4.55 %

Cannabis Sativa Stock Sales Revenue, EBIT, Earnings per Share

The Cannabis Sativa earnings per share therefore indicates how much revenue Cannabis Sativa has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cannabis Sativa earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cannabis Sativa's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cannabis Sativa’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cannabis Sativa's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Cannabis Sativa Revenue, EBIT and net profit per share

DateCannabis Sativa Sales per ShareCannabis Sativa EBIT per shareCannabis Sativa Earnings per Share
20230.02 undefined-0.02 undefined-0.03 undefined
20220.04 undefined-0.03 undefined-0.03 undefined
20210.06 undefined-0.06 undefined-0.08 undefined
20200.08 undefined-0.07 undefined-0.09 undefined
20190.05 undefined-0.11 undefined-0.18 undefined
20180.02 undefined-0.18 undefined-0.2 undefined
20170.02 undefined-0.34 undefined-0.38 undefined
20160 undefined-0.16 undefined-0.18 undefined
20150 undefined-0.55 undefined-0.58 undefined
20140 undefined-0.11 undefined-1.14 undefined
20130 undefined-0.02 undefined-4.16 undefined
20120.11 undefined-0.03 undefined-0.03 undefined
20110.14 undefined-0.01 undefined-0.02 undefined
20100.13 undefined-0.03 undefined-0.03 undefined
20090.14 undefined-0.03 undefined-0.03 undefined
20080.18 undefined0 undefined0 undefined
20070.17 undefined0.02 undefined0.01 undefined

Cannabis Sativa business model

Cannabis Sativa Inc is a company based in the USA that specializes in the production and distribution of medical cannabis and hemp products. The company was founded in 2005 and has since grown steadily. Its business model is based on the processing and sale of hemp products and medical cannabis. The company aims to offer high-quality products suitable for both medical and recreational use. It operates various divisions to provide a comprehensive range of products. One of these divisions focuses on processing cannabis products into oils, creams, and other medical products. Emphasis is placed on high quality and careful production to ensure maximum effectiveness and compatibility. Another important area is hemp products such as CBD oils or hemp seeds. The company also works with the highest quality and strict standards to offer its customers the best possible products. In addition to production and sales, Cannabis Sativa also offers consultation and support for the use of medical cannabis and hemp products. Experts and medical professionals are available to ensure the best possible application and dosage. One particularly important project is the development of Botanical Genetics, a subsidiary of Cannabis Sativa. Research is conducted on new cannabis strains to improve their effectiveness and medical applications. This includes the development of new products based on CBD and other cannabinoids that can be used to treat various illnesses. In the past, Cannabis Sativa has also invested in research and collaborated closely with universities and medical institutions to study and improve the effects of medical cannabis. Overall, Cannabis Sativa is an innovative company specializing in the production and distribution of high-quality hemp and cannabis products. With its various divisions and projects, it offers a wide range of products and services. With a focus on medical applications and research on new cannabis strains, the company is an important player in the hemp and cannabis product market. Cannabis Sativa is one of the most popular companies on Eulerpool.com.

Cannabis Sativa Revenue by Segment

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Cannabis Sativa Revenue by Segment

Segmente2020
PrestoCorp1.94 M USD
GKMP94,552 USD
Other577 USD

Cannabis Sativa SWOT Analysis

Strengths

Cannabis Sativa Inc has a strong brand presence with a diversified product portfolio that includes various cannabis-based offerings.

The company has developed a strong distribution network, enabling them to reach a wide range of customers in both medical and recreational markets.

Cannabis Sativa Inc has a robust research and development team, allowing them to innovate and develop new products to meet consumer demands.

Weaknesses

The company is highly dependent on the regulatory environment surrounding cannabis, which can be unpredictable and subject to frequent changes.

Cannabis Sativa Inc faces intense competition in the cannabis industry, with other established players as well as new entrants constantly vying for market share.

The company's production and cultivation capabilities may not be on par with some of its larger competitors, hampering scalability.

Opportunities

The legalization and decriminalization of cannabis in various regions present significant opportunities for growth and market expansion for Cannabis Sativa Inc.

The increasing acceptance and interest in cannabis-based medicinal products opens up potential partnerships and collaborations with healthcare organizations.

International markets, where cannabis regulations are evolving, offer potential avenues for geographic diversification and increased revenue streams.

Threats

Continued regulatory uncertainty and restrictions on cannabis use at the federal level pose significant threats to the company's operations and market reach.

Fluctuations in consumer preferences, as well as pricing pressures, may impact demand for Cannabis Sativa Inc's products.

Negative public perception and stigma associated with cannabis use may limit the company's ability to attract new customers or face public backlash.

Cannabis Sativa Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Cannabis Sativa historical P/E ratio, EBIT multiple, and P/S ratio

Cannabis Sativa shares outstanding

The number of shares was Cannabis Sativa in 2023 — This indicates how many shares 54.554 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Cannabis Sativa earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Cannabis Sativa's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Cannabis Sativa’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cannabis Sativa's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Cannabis Sativa.

Cannabis Sativa shareholders

%
Name
Stocks
Change
Date
14.04155 % Tobias (David)15,181,7256,200,00012/19/2023
6.16093 % Merrill (Carolyn)6,661,1986,661,19812/19/2023
4.39694 % New Compendium Corp4,753,9672,559,5652/1/2023
1.44468 % Barrameda (Sadia P)1,561,986900,9402/1/2023
1.15770 % Carroll (Catherine J)1,251,707410,3402/1/2023
0.19934 % Reed (Trevor S)215,53028,6462/1/2023
0.07210 % Tankson (Robert N. III)77,95128,6462/1/2023
0.00009 % Winch Financial9309/30/2024
1

Cannabis Sativa Executives and Management Board

Mr. David Tobias70
Cannabis Sativa President, Chief Executive Officer, Secretary, Director (since 2013)
Compensation 175,964
Ms. Catherine Carroll80
Cannabis Sativa Treasurer, Director (since 2013)
Compensation 175,964
Mr. Robert Tankson34
Cannabis Sativa Director
Mr. Trevor Reed57
Cannabis Sativa Independent Director
1

Most common questions regarding Cannabis Sativa

What values and corporate philosophy does Cannabis Sativa represent?

Cannabis Sativa Inc represents values of innovation, quality, and a commitment to cannabis research and development. The company believes in the potential therapeutic benefits of cannabis and its products. With a focus on sustainability and eco-friendly practices, Cannabis Sativa Inc aims to provide premium cannabis options to consumers. Emphasizing transparency and integrity, the company strives to maintain strong corporate governance and compliance. By leveraging its expertise and dedication, Cannabis Sativa Inc aims to create a positive impact on the cannabis industry and contribute to the overall well-being of individuals.

In which countries and regions is Cannabis Sativa primarily present?

Cannabis Sativa Inc is primarily present in the United States.

What significant milestones has the company Cannabis Sativa achieved?

Cannabis Sativa Inc has achieved significant milestones in the cannabis industry. The company has successfully expanded its reach by establishing various subsidiaries, including Hi Brands International, Wild Earth Naturals, and PrestoDoctor. In 2014, Cannabis Sativa Inc became one of the first publicly traded companies in the United States focused on the legal cannabis market. Moreover, the company has been actively involved in research and development of various cannabis-based products, including wellness and therapeutic solutions. With a commitment to innovation and growth, Cannabis Sativa Inc continues to pave the way in the cannabis industry, positioning itself as a leading player in this rapidly evolving market.

What is the history and background of the company Cannabis Sativa?

Cannabis Sativa Inc is a company with a rich history and background. Established in 2005, it has become a prominent player in the cannabis industry. The company is focused on developing and promoting cannabis-based products, including CBD and THC solutions. With a diverse range of offerings, Cannabis Sativa Inc has positioned itself as a leader in the rapidly expanding market. Its dedication to quality and innovation has earned the company a strong reputation among consumers and investors alike. As a forward-thinking company, Cannabis Sativa Inc continues to explore new opportunities and partnerships to further expand its presence in the cannabis industry.

Who are the main competitors of Cannabis Sativa in the market?

The main competitors of Cannabis Sativa Inc in the market include companies such as Canopy Growth Corporation, Aurora Cannabis Inc, and Tilray Inc.

In which industries is Cannabis Sativa primarily active?

Cannabis Sativa Inc is primarily active in the cannabis industry.

What is the business model of Cannabis Sativa?

The business model of Cannabis Sativa Inc involves the cultivation, manufacturing, and distribution of cannabis-related products. As a company focused on the cannabis industry, Cannabis Sativa Inc aims to capitalize on the growing market demand for both medical and recreational use of cannabis. With a diverse range of products including cannabis strains, edibles, and extracts, the company aims to cater to the evolving needs and preferences of its customers. By maintaining a strong presence in the cannabis market and continually expanding its product offerings, Cannabis Sativa Inc strives to establish itself as a leading player in the industry.

What is the P/E ratio of Cannabis Sativa 2024?

The P/E ratio cannot be calculated for Cannabis Sativa at the moment.

What is the P/S ratio of Cannabis Sativa 2024?

The P/S cannot be calculated for Cannabis Sativa currently.

What is the Quality Investing of Cannabis Sativa?

The Quality Investing for Cannabis Sativa is 4/10.

What is the revenue of Cannabis Sativa 2024?

The revenue cannot currently be calculated for Cannabis Sativa.

How high is the profit of Cannabis Sativa 2024?

The profit cannot currently be calculated for Cannabis Sativa.

What is the business model of Cannabis Sativa

Cannabis Sativa Inc. is an American company based in Nevada that operates in the exciting world of the cannabis plant. The company offers a wide range of products and services centered around the cannabis plant, with the goal of changing the perception of cannabis as a legal and medically useful herb. Its business areas include CBD products, medical cannabis, and hemp textiles. Cannabis Sativa Inc. aims to promote understanding of cannabis and its potential to improve overall well-being.

What is the Cannabis Sativa dividend?

Cannabis Sativa pays a dividend of 0 USD distributed over payouts per year.

How often does Cannabis Sativa pay dividends?

The dividend cannot currently be calculated for Cannabis Sativa or the company does not pay out a dividend.

What is the Cannabis Sativa ISIN?

The ISIN of Cannabis Sativa is US13764T1051.

What is the Cannabis Sativa WKN?

The WKN of Cannabis Sativa is A1W820.

What is the Cannabis Sativa ticker?

The ticker of Cannabis Sativa is CBDS.

How much dividend does Cannabis Sativa pay?

Over the past 12 months, Cannabis Sativa paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cannabis Sativa is expected to pay a dividend of 0 USD.

What is the dividend yield of Cannabis Sativa?

The current dividend yield of Cannabis Sativa is .

When does Cannabis Sativa pay dividends?

Cannabis Sativa pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cannabis Sativa?

Cannabis Sativa paid dividends every year for the past 0 years.

What is the dividend of Cannabis Sativa?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cannabis Sativa located?

Cannabis Sativa is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cannabis Sativa kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cannabis Sativa from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Cannabis Sativa pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Cannabis Sativa in the year 2023?

In the year 2023, Cannabis Sativa distributed 0 USD as dividends.

In which currency does Cannabis Sativa pay out the dividend?

The dividends of Cannabis Sativa are distributed in USD.

All fundamentals about Cannabis Sativa

Our stock analysis for Cannabis Sativa Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cannabis Sativa Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.